Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Alternative RNA splicing and cancer.

Liu S, Cheng C.

Wiley Interdiscip Rev RNA. 2013 Sep-Oct;4(5):547-66. doi: 10.1002/wrna.1178. Review.

2.

Regulation of mammalian pre-mRNA splicing.

Hui J.

Sci China C Life Sci. 2009 Mar;52(3):253-60. doi: 10.1007/s11427-009-0037-0. Review.

PMID:
19294350
3.

Regulation of apoptosis by alternative pre-mRNA splicing.

Schwerk C, Schulze-Osthoff K.

Mol Cell. 2005 Jul 1;19(1):1-13. Review.

4.
5.

Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged.

David CJ, Manley JL.

Genes Dev. 2010 Nov 1;24(21):2343-64. doi: 10.1101/gad.1973010. Review.

6.

[Pre-mRNA alternative splicing in cancer: functional impact, molecular mechanisms and therapeutic perspectives].

Revil T, Shkreta L, Chabot B.

Bull Cancer. 2006 Sep;93(9):909-19. Review. French.

7.

Non-coding functions of alternative pre-mRNA splicing in development.

Mockenhaupt S, Makeyev EV.

Semin Cell Dev Biol. 2015 Dec;47-48:32-9. doi: 10.1016/j.semcdb.2015.10.018. Review.

8.

Misregulation of pre-mRNA alternative splicing in cancer.

Zhang J, Manley JL.

Cancer Discov. 2013 Nov;3(11):1228-37. doi: 10.1158/2159-8290.CD-13-0253. Review.

9.

[Disturbances of alternative splicing in cancer].

Wiszomirska H, Piekiełko-Witkowska A, Nauman A.

Postepy Biochem. 2011;57(3):257-65. Review. Polish.

PMID:
22235651
10.

Mechanisms and Regulation of Alternative Pre-mRNA Splicing.

Lee Y, Rio DC.

Annu Rev Biochem. 2015;84:291-323. doi: 10.1146/annurev-biochem-060614-034316. Review.

11.

Regulation of chemoresistance via alternative messenger RNA splicing.

Eblen ST.

Biochem Pharmacol. 2012 Apr 15;83(8):1063-72. doi: 10.1016/j.bcp.2011.12.041. Review.

12.

[A progress toward research on alternative splicing of genes in tumor cells].

Zhou ZR, Sun KL.

Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2006 Apr;23(2):177-80. Review. Chinese.

PMID:
16604490
13.

Small Molecule Modulators of Pre-mRNA Splicing in Cancer Therapy.

Salton M, Misteli T.

Trends Mol Med. 2016 Jan;22(1):28-37. doi: 10.1016/j.molmed.2015.11.005. Review.

14.

[Perspectives of RNA interference application in the therapy of diseases associated with defects in alternative RNA splicing].

Wysokiński D, Błasiak J.

Postepy Hig Med Dosw (Online). 2012 Sep 18;66:683-95. Review. Polish.

15.

Alternative pre-mRNA splicing.

Wagner SD, Berglund JA.

Methods Mol Biol. 2014;1126:45-54. doi: 10.1007/978-1-62703-980-2_4.

PMID:
24549655
16.

[The application of bioinformatics in the research of alternative splicing].

Lin LP, Ma F, Wang YQ.

Yi Chuan. 2005 Nov;27(6):1001-6. Review. Chinese.

PMID:
16378953
17.

Control of alternative splicing by signal-dependent degradation of splicing-regulatory proteins.

Katzenberger RJ, Marengo MS, Wassarman DA.

J Biol Chem. 2009 Apr 17;284(16):10737-46. doi: 10.1074/jbc.M809506200.

18.

[The epigenetic effect on pre-mRNA alternative splicing].

Zhao J, Wang F, Xu Z, Fan Y.

Yi Chuan. 2014 Mar;36(3):248-55. Review. Chinese.

PMID:
24846965
19.

Distinct functions of SR proteins in alternative pre-mRNA splicing.

Zahler AM, Neugebauer KM, Lane WS, Roth MB.

Science. 1993 Apr 9;260(5105):219-22.

PMID:
8385799
20.

Role of precursor mRNA splicing in nutrient-induced alterations in gene expression and metabolism.

Ravi S, Schilder RJ, Kimball SR.

J Nutr. 2015 May;145(5):841-6. doi: 10.3945/jn.114.203216. Review.

Items per page

Supplemental Content

Support Center